Brukinsa
E2108051
UNEXPLORED
Brukinsa is a targeted cancer therapy drug (a Bruton’s tyrosine kinase inhibitor) used to treat certain types of B-cell malignancies such as mantle cell lymphoma and Waldenström’s macroglobulinemia.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Brukinsa canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.